Zimmer Biomet Holdings Cash Flow from Operating Activities 2010-2024 | ZBH
Zimmer Biomet Holdings annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Zimmer Biomet Holdings cash flow from operating activities for the quarter ending December 31, 2024 was $1.499B, a 5.2% decline year-over-year.
- Zimmer Biomet Holdings cash flow from operating activities for the twelve months ending December 31, 2024 was $3.318B, a 6.22% decline year-over-year.
- Zimmer Biomet Holdings annual cash flow from operating activities for 2024 was $1.499B, a 5.2% decline from 2023.
- Zimmer Biomet Holdings annual cash flow from operating activities for 2023 was $1.582B, a 16.62% increase from 2022.
- Zimmer Biomet Holdings annual cash flow from operating activities for 2022 was $1.356B, a 3.43% decline from 2021.
| Zimmer Biomet Holdings Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $1,499 |
| 2023 | $1,582 |
| 2022 | $1,356 |
| 2021 | $1,404 |
| 2020 | $1,076 |
| 2019 | $1,586 |
| 2018 | $1,747 |
| 2017 | $1,582 |
| 2016 | $1,632 |
| 2015 | $850 |
| 2014 | $1,061 |
| 2013 | $963 |
| 2012 | $1,152 |
| 2011 | $1,177 |
| 2010 | $1,194 |
| 2009 | $1,118 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $20.255B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||